Treatment of the infected implant site using platelet-rich plasma.
Implant therapy has become a highly effective treatment modality for patients seeking the replacement of lost dentition. Potential complications in the delivery of implant therapy may cause either failure of implant integration or the development of peri-implantitis. In an effort to enhance the healing phase in the treatment of the infected implant site, the incorporation of platelet-rich plasma and its growth factors has been introduced into the surgical protocol. Documentation of cases requiring the treatment of infected implant sites with combined bone grafting, tissue regeneration, and enhanced healing phase management with platelet-rich plasma is presented.
Petrungaro
Paul S
PS
D000543:Alveoloplasty; D001792:Blood Platelets / Q000502:physiology; D001804:Blood Transfusion, Autologous / Q000379:methods; D016025:Bone Transplantation; D003646:Debridement; D015921:Dental Implants; D019232:Dental Restoration Failure; D006133:Growth Substances / Q000627:therapeutic use*; D016557:Guided Tissue Regeneration, Periodontal; D006801:Humans; D008297:Male; D008875:Middle Aged; D016348:Osseointegration; D010518:Periodontitis / Q000601:surgery*; D017713:Platelet Transfusion / Q000379:methods; D014945:Wound Healing
D015921:Dental Implants; D006133:Growth Substances